361 related articles for article (PubMed ID: 6895662)
1. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
Chan JC; Kodroff MB; Landwehr DM
Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
[TBL] [Abstract][Full Text] [Related]
2. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
Chan JC; Lovinger RD; Mamunes P
Pediatrics; 1980 Sep; 66(3):445-54. PubMed ID: 6893489
[TBL] [Abstract][Full Text] [Related]
3. Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy.
Chesney RW; Moorthy AV; Eisman JA; Jax DK; Mazess RB; DeLuca HF
N Engl J Med; 1978 Feb; 298(5):238-42. PubMed ID: 201843
[TBL] [Abstract][Full Text] [Related]
4. [Effect of treatment with 1,25-dihydroxyvitamin D3 in children with chronic renal insufficiency].
Rey Galaán C; Riaño Galán I; del Molino Anta A; Santos Rodríguez F; Málaga Guerrero S; Crespo Hernández M
An Esp Pediatr; 1987 Nov; 27(5):335-8. PubMed ID: 3439654
[TBL] [Abstract][Full Text] [Related]
5. Effects of 1,25-dihydroxyvitamin-D3 treatment on mineral balance in children with end stage renal disease undergoing chronic hemofiltration.
Bettinelli A; Bianchi ML; Aimini E; Ortolani S; Soldati L; Edefonti A
Pediatr Res; 1986 Jan; 20(1):5-8. PubMed ID: 3753754
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D replacement therapy and renal function. Calcitriol v dihydrotachysterol.
Hymes LC; Warshaw BL
Am J Dis Child; 1984 Dec; 138(12):1125-8. PubMed ID: 6548870
[TBL] [Abstract][Full Text] [Related]
7. Renal hypophosphatemic rickets. Growth and mineral metabolism after treatment with calcitriol (1,25-dihydroxyvitamin D3) and phosphate supplementation.
Tsuru N; Chan JC; Chinchilli VM
Am J Dis Child; 1987 Jan; 141(1):108-10. PubMed ID: 3788870
[TBL] [Abstract][Full Text] [Related]
8. Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication.
Hsu AC; Kooh SW; Fraser D; Cumming WA; Fornasier VL
Pediatrics; 1982 Nov; 70(5):742-50. PubMed ID: 6982452
[TBL] [Abstract][Full Text] [Related]
9. The use of 1,25-dihydroxyvitamin D3 in early renal failure.
Goodman WG; Coburn JW
Annu Rev Med; 1992; 43():227-37. PubMed ID: 1580587
[TBL] [Abstract][Full Text] [Related]
10. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
Saggese G; Baroncelli GI; Bertelloni S; Perri G
J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
[TBL] [Abstract][Full Text] [Related]
11. Renal osteodystrophy in children: the role of vitamin D, phosphorus, and parathyroid hormone.
Chesney RW; Mehls O; Anast CS; Brown E; Hammerman MR; Portale A; Fallon MD; Mahan J; Alfrey AC
Am J Kidney Dis; 1986 Apr; 7(4):275-84. PubMed ID: 3515907
[No Abstract] [Full Text] [Related]
12. Decreased renal function in association with administration of 1,25-dihydroxyvitamin D3 to patients with stable, advanced renal failure.
Christiansen C; Røodbro P; Christensen MS; Naestoft J; Hartnack B; Transbøol I
Contrib Nephrol; 1980; 18():139-46. PubMed ID: 6243527
[TBL] [Abstract][Full Text] [Related]
13. Long-term therapy of uremic osteodystrophy in adults with calcitriol.
Moorthy AV; Harrington AR; Mazess RB; Simpson DP
Clin Nephrol; 1981 Aug; 16(2):93-100. PubMed ID: 6894893
[TBL] [Abstract][Full Text] [Related]
14. Hypophosphatemic rickets: effect of 1 alpha, 25-dihydroxyvitamin D3 on growth and mineral metabolism.
Chan JC; Bartter FC
Pediatrics; 1979 Oct; 64(4):488-95. PubMed ID: 492815
[TBL] [Abstract][Full Text] [Related]
15. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
[TBL] [Abstract][Full Text] [Related]
17. 1 alpha-hydroxy vitamin D3 treatment of non-dialyzed patients with chronic renal failure. Effects on bone, mineral metabolism and kidney function.
Nielsen HE; Rømer FK; Melsen F; Christensen MS; Hansen HE
Clin Nephrol; 1980 Mar; 13(3):103-8. PubMed ID: 7379358
[TBL] [Abstract][Full Text] [Related]
18. Effects of 25-OHD3 on renal function in pediatric patients with chronic renal failure.
Mazur AT; Norman ME
Miner Electrolyte Metab; 1984; 10(6):351-8. PubMed ID: 6503891
[TBL] [Abstract][Full Text] [Related]
19. Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.
Massry SG; Goldstein DA; Malluche HH
Kidney Int; 1980 Oct; 18(4):409-18. PubMed ID: 7014981
[No Abstract] [Full Text] [Related]
20. Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophy.
Muirhead N; Adami S; Sandler LM; Fraser RA; Catto GR; Edward N; O'Riordan JL
Q J Med; 1982; 51(204):427-44. PubMed ID: 6760236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
